WntResearch announces that patient recruitment for initial safety assessment has been successfully achieved
An important milestone is reached as WntResearch enrolls the twentieth patient in the NeoFox trial; this means that the recruitment target for performing the initial safety assessment has been reached.WntResearch's Phase 2 study has now enrolled patient number 20, and an initial safety assessment will be performed on these patients once they have completed treatment, which according to plan will be in February 2020 at the latest. The Company is now seeing a significantly improved patient recruitment following the measures that have been adopted in the clinics, resulting in 6 new patients